ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 198 filers reported holding ROYALTY PHARMA PLC in Q4 2020. The put-call ratio across all filers is 2.07 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,161,000 | -20.3% | 153,298 | -9.7% | 0.02% | -9.5% |
| Q2 2023 | $5,219,000 | -23.5% | 169,782 | -10.3% | 0.02% | -25.0% |
| Q1 2023 | $6,821,000 | -11.2% | 189,320 | -2.5% | 0.03% | -15.2% |
| Q4 2022 | $7,677,000 | +0.8% | 194,268 | +2.5% | 0.03% | -2.9% |
| Q3 2022 | $7,618,000 | -2.4% | 189,596 | +2.1% | 0.03% | +3.0% |
| Q2 2022 | $7,808,000 | -15.1% | 185,727 | -21.3% | 0.03% | +3.1% |
| Q1 2022 | $9,200,000 | +31.2% | 236,141 | +34.2% | 0.03% | +33.3% |
| Q4 2021 | $7,011,000 | +6.4% | 175,939 | -3.5% | 0.02% | +4.3% |
| Q3 2021 | $6,588,000 | -13.6% | 182,299 | -2.0% | 0.02% | -14.8% |
| Q2 2021 | $7,627,000 | +1.7% | 186,071 | +8.3% | 0.03% | -10.0% |
| Q1 2021 | $7,496,000 | +180.1% | 171,839 | +221.4% | 0.03% | +150.0% |
| Q4 2020 | $2,676,000 | – | 53,466 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $244,378,000 | 79.54% |
| Vantage Consulting Group Inc | 7,862,542 | $284,152,000 | 60.85% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $96,878,000 | 60.36% |
| Indie Asset Partners, LLC | 701,323 | $25,346,000 | 20.53% |
| HARVARD MANAGEMENT CO INC | 7,142,856 | $258,143,000 | 15.13% |
| Bleichroeder LP | 1,115,980 | $40,332,000 | 6.55% |
| Overbrook Management Corp | 785,132 | $28,375,000 | 6.16% |
| Geo Capital Gestora de Recursos Ltd | 194,305 | $7,022,000 | 3.21% |
| Brown University | 621,759 | $22,470,000 | 3.05% |
| Graypoint LLC | 610,584 | $22,067,000 | 2.71% |